EndureCARTTM: CAR-T Platform with Persistent Efficacy
Harnessing our technology platform to achieve sustained activation with CAR-T cells, leading the way in the next generation of CAR-T cell therapy.
DISCOVER MORE
Welcome to our EndureCARTTM technology platform, transforming cellular therapies with improved intracellular domain modifications. Our platform optimizes the signaling cascade post-CAR receptor activation for continuous T-cell proliferation and activation.
As a provider of CAR-T research solutions, we offer customized services for your CAR-T therapy development using our state-of-the-art technology platform and comprehensive research services.
Innovative Therapies
Advanced Technology
Customized Solutions
Professional Knowledge
5000+
Satisfied Clients
Leading in cell therapy advancements, our CAR-T development platform ensures continuous activation of CAR-T cells. It provides lasting therapeutic results, establishing us as the premier option for CAR-T therapeutic development services providers.
Using the groundbreaking EndureCARTTM platform, we offer tailored services to clients in the CAR-T therapy development industry, covering target identification, CAR molecular design, in vitro and in vivo efficacy testing, and safety assessment.
The design and screening of CAR constructs to achieve better disease therapeutic efficacy.
The CAR construct is introduced into T cells using viral vectors or other gene transfer methods.
Rigorous in vitro testing ensures that the modified T cells meet safety and efficacy standards.
Animal models of various diseases are used for in vivo studies of CAR-T therapy.
Solid and Liquid Tumors
Autoimmune Diseases
Infectious Diseases
Neurological Disorders
The application areas of CAR-T therapy development span across various domains in oncology and beyond. By utilizing our EndureCARTTM technology platform, CAR molecules can be created for specific targets, enabling the design and modification of CAR-T cells for precise targeted therapy across various disease research domains.
Precise targeting for different diseases
Durable response of CAR-T cell
Customized therapeutic development
Selecting our CAR-T development platform can result in sustained activation and improve the therapeutic efficacy of CAR-T cells. Additionally, we offer extensive research services for CAR-T therapies at any developmental phase.
Cutting-edge Technology Platform: Harness our revolutionary EndureCARTTM platforms for tailored therapy development.
Customized Solutions: We provide personalized solutions catering to specific antigens and CAR-T therapy development needs.
Professional Support: Our team of experienced experts in cellular therapy, ensures top-tier service quality.
Please feel free to contact us for details on our services or with any inquiries regarding CAR-T therapy development.
Our EndureCARTTM technology platform enables the sustained activation of CAR-T cells for enduring responses. We offer customized CAR-T therapy development services tailored to your requirements, fostering innovation in cell therapy.
Copyright © Protheragen. All rights reserved.
